Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2116011 | Cancer Letters | 2006 | 9 Pages |
Abstract
BARD1 is a crucial partner of the breast and ovarian tumor suppressor BRCA1 required for ubiquitin ligase activity and for reciprocal stabilization in cells. We report here an alternatively spliced human BARD1 mRNA variant (BARD1ΔRIN) isolated from a HeLa cell cDNA library. It is characterized by deletion of exons 2–6 that encode most of the RING finger domain and the entire span of ankyrin repeats. ΔRIN transcript was detected in all breast cancer-cell lines studied although its protein expression level was low. ΔRIN does not interact with BRCA1, whereas it interacts with and colocalizes with CstF-50 to cytoplasmic dots. Hence, a deletion variant of BARD1 occurs in cells and may play a distinct role with CstF-50.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Makiko Tsuzuki, Wenwen Wu, Hiroyuki Nishikawa, Ryosuke Hayami, Daisuke Oyake, Yukari Yabuki, Mamoru Fukuda, Tomohiko Ohta,